Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1631326

Cover Image

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1631326

Global Arterial Cannula Market Size study, by Application (Cardiopulmonary Bypass Surgery, Extracorporeal Membrane Oxygenation, Others), by Size, by End-use, and Regional Forecasts 2022-2032

PUBLISHED:
PAGES: 285 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4950
Printable PDF (Enterprise License)
USD 6250

Add to Cart

The Global Arterial Cannula Market is valued at approximately USD 20.28 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.50% over the forecast period 2024-2032. Arterial cannulas, critical medical devices, are extensively utilized in life-support procedures like cardiopulmonary bypass surgeries and ECMO. Their ability to facilitate the seamless transfer of oxygenated blood underscores their indispensable role in healthcare. These devices are tailored for precision, ensuring patient safety and optimal therapeutic outcomes. With a surge in cardiovascular diseases globally and an uptick in surgical interventions, the demand for arterial cannulas is experiencing exponential growth. Moreover, innovations focusing on biocompatibility and performance efficiency continue to redefine this market, pushing the boundaries of medical capabilities.

The arterial cannula market has witnessed significant advancements, with the development of cannulas designed to address specific medical needs. For instance, smaller cannula sizes have been engineered to minimize vascular trauma during procedures, a breakthrough particularly valuable in pediatric and neonatal care. Additionally, the integration of advanced materials has enhanced device durability and reduced the risk of thrombosis. Despite the promising outlook, challenges such as high procedural costs and stringent regulatory frameworks could act as roadblocks. However, the increasing prevalence of chronic diseases and the adoption of minimally invasive techniques are expected to counterbalance these limitations, propelling the market forward.

The geographical landscape of the arterial cannula market reveals diverse trends and opportunities. North America, with its robust healthcare infrastructure and significant R&D investments, dominates the market, driven by the high prevalence of cardiovascular diseases and cutting-edge surgical techniques. Europe follows closely, supported by progressive medical policies and advanced healthcare systems. Meanwhile, the Asia-Pacific region is poised to witness the fastest growth, fueled by increasing healthcare expenditure, a rising geriatric population, and expanding medical tourism. Emerging economies such as India and China are at the forefront of this growth, presenting lucrative opportunities for market players.

Major market players included in this report are:

  • Medtronic
  • Edward Lifesciences Corporation
  • LivaNova PLC
  • Terumo Corporation
  • Getinge AB
  • Abbott Laboratories
  • Smiths Medical
  • Boston Scientific Corporation
  • B. Braun Melsungen AG
  • Teleflex Incorporated
  • Andocor N.V.
  • BD (Becton, Dickinson, and Company)
  • Merit Medical Systems
  • Cook Medical
  • Fresenius Medical Care AG & Co. KGaA

The detailed segments and sub-segment of the market are explained below:

By Application:

  • Cardiopulmonary Bypass Surgery
  • Extracorporeal Membrane Oxygenation (ECMO)
  • Others

By Size:

  • 20-22 Fr
  • 35-36 Fr

By End-use:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Rest of Europe
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional-level analysis for each market segment.
  • Detailed analysis of the geographical landscape with country-level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approaches.
  • Analysis of the competitive structure of the market.
  • Demand-side and supply-side analysis of the market.

Table of Contents

Chapter 1. Global Arterial Cannula Market Executive Summary

  • 1.1. Global Arterial Cannula Market Size & Forecast (2022-2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By Application
    • 1.3.2. By Size
    • 1.3.3. By End-use
  • 1.4. Key Trends
  • 1.5. Recession Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Arterial Cannula Market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability
      • 2.3.3.2. Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Consumer's Perspective)
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Regulatory Frameworks
      • 2.3.4.2. Technological Advancements
      • 2.3.4.3. Environmental Considerations
      • 2.3.4.4. Consumer Awareness & Acceptance
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Arterial Cannula Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Surge in Cardiovascular Diseases and Surgical Interventions
    • 3.1.2. Innovations in Biocompatibility and Performance Efficiency
    • 3.1.3. Increasing Prevalence of Chronic Diseases
  • 3.2. Market Challenges
    • 3.2.1. High Procedural Costs
    • 3.2.2. Stringent Regulatory Frameworks
  • 3.3. Market Opportunities
    • 3.3.1. Adoption of Minimally Invasive Techniques
    • 3.3.2. Expanding Healthcare Infrastructure in Emerging Markets
    • 3.3.3. Growing Demand for Advanced Surgical Interventions

Chapter 4. Global Arterial Cannula Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top Investment Opportunities
  • 4.4. Top Winning Strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Arterial Cannula Market Size & Forecasts by Application 2022-2032

  • 5.1. Segment Dashboard
  • 5.2. Global Arterial Cannula Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
    • 5.2.1. Cardiopulmonary Bypass Surgery
    • 5.2.2. Extracorporeal Membrane Oxygenation (ECMO)
    • 5.2.3. Others

Chapter 6. Global Arterial Cannula Market Size & Forecasts by Size 2022-2032

  • 6.1. Segment Dashboard
  • 6.2. Global Arterial Cannula Market: Size Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
    • 6.2.1. 20-22 Fr
    • 6.2.2. 35-36 Fr

Chapter 7. Global Arterial Cannula Market Size & Forecasts by End-use 2022-2032

  • 7.1. Segment Dashboard
  • 7.2. Global Arterial Cannula Market: End-use Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
    • 7.2.1. Hospitals
    • 7.2.2. Ambulatory Surgical Centers
    • 7.2.3. Others

Chapter 8. Global Arterial Cannula Market Size & Forecasts by Region 2022-2032

  • 8.1. North America Arterial Cannula Market
    • 8.1.1. U.S. Arterial Cannula Market
      • 8.1.1.1. Application Breakdown Size & Forecasts, 2022-2032
      • 8.1.1.2. Size Breakdown Size & Forecasts, 2022-2032
    • 8.1.2. Canada Arterial Cannula Market
  • 8.2. Europe Arterial Cannula Market
    • 8.2.1. UK Arterial Cannula Market
    • 8.2.2. Germany Arterial Cannula Market
    • 8.2.3. France Arterial Cannula Market
    • 8.2.4. Spain Arterial Cannula Market
    • 8.2.5. Italy Arterial Cannula Market
    • 8.2.6. Rest of Europe Arterial Cannula Market
  • 8.3. Asia-Pacific Arterial Cannula Market
    • 8.3.1. China Arterial Cannula Market
    • 8.3.2. India Arterial Cannula Market
    • 8.3.3. Japan Arterial Cannula Market
    • 8.3.4. Australia Arterial Cannula Market
    • 8.3.5. South Korea Arterial Cannula Market
    • 8.3.6. Rest of Asia-Pacific Arterial Cannula Market
  • 8.4. Latin America Arterial Cannula Market
    • 8.4.1. Brazil Arterial Cannula Market
    • 8.4.2. Mexico Arterial Cannula Market
    • 8.4.3. Rest of Latin America Arterial Cannula Market
  • 8.5. Middle East & Africa Arterial Cannula Market
    • 8.5.1. Saudi Arabia Arterial Cannula Market
    • 8.5.2. South Africa Arterial Cannula Market
    • 8.5.3. Rest of Middle East & Africa Arterial Cannula Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Medtronic
    • 9.1.2. Edward Lifesciences Corporation
    • 9.1.3. Abbott Laboratories
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Medtronic
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Market Strategies
    • 9.3.2. Edward Lifesciences Corporation
    • 9.3.3. LivaNova PLC
    • 9.3.4. Terumo Corporation
    • 9.3.5. Getinge AB
    • 9.3.6. Smiths Medical
    • 9.3.7. Boston Scientific Corporation
    • 9.3.8. B. Braun Melsungen AG
    • 9.3.9. Teleflex Incorporated
    • 9.3.10. Andocor N.V.
    • 9.3.11. BD (Becton, Dickinson, and Company)
    • 9.3.12. Merit Medical Systems
    • 9.3.13. Cook Medical
    • 9.3.14. Fresenius Medical Care AG & Co. KGaA

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!